Telaprevir-Based Regimens More Effective Than Standard Of Care In Curing HCV Genotype 1 Patients Who Failed Previous Therapy

[Guest guest]

Telaprevir-Based Regimens More Effective Than Standard Of Care In Curing HCV Genotype 1 Patients Who Failed Previous TherapyData from the PROVE3 trial published today in the New England Journal of Medicine show that telaprevir-based regimens are significantly more effective than the current standard of care in helping patients with chronic genotype 1 hepatitis C virus (HCV) who failed previous therapy achieve a sustained virologic response (SVR)...To read the full article, please go to:http://www.medicalnewstoday.com/articles/184973.php************************************************************